Hepatocellular adenoma: Where are we now?

World J Gastroenterol. 2022 Apr 14;28(14):1384-1393. doi: 10.3748/wjg.v28.i14.1384.

Abstract

Hepatocellular adenoma (HCA) is a benign hepatocellular neoplasm, commonly occurs in young women with a history of oral contraceptive use. Complications including hemorrhage and malignant transformation necessitate the need for a thorough understanding of the underlying molecular signatures in this entity. Recent molecular studies have significantly expanded our knowledge of HCAs. The well-developed phenotype-genotype classification system improves clinical management through identifying "high risk" subtype of HCAs. In this article, we attempt to provide updated information on clinical, pathologic and molecular features of each subtype of HCAs.

Keywords: Classification; Hepatocellular adenoma; Hepatocellular carcinoma; Pathology; Subtype.

Publication types

  • Editorial

MeSH terms

  • Adenoma, Liver Cell* / genetics
  • Adenoma, Liver Cell* / therapy
  • Carcinoma, Hepatocellular* / complications
  • Carcinoma, Hepatocellular* / genetics
  • Carcinoma, Hepatocellular* / therapy
  • Cell Transformation, Neoplastic
  • Female
  • Hemorrhage
  • Humans
  • Liver Neoplasms* / genetics
  • Liver Neoplasms* / therapy